CRITICA Pharma

is an emerging specialty pharma specialized in the commercialization of innovative pharmaceutical products, with emphasis on orphan and “added value” drugs.

We help our Partners

to expand their commercial activities in often neglected territories and enter new markets segments, specialize, improve performance, and stimulate growth.

We have Access

to Greece and the Mediterranean Island States of Cyprus and Malta (a region with 12 million potential customers) with an outstanding commercial, medical, legal, and cultural expertise.

We Develop

New formulas and new pharmaceutical solutions for the global healthcare industry. Our current focus is on re-engineering anti-infective and anti-fungal injectable “add on” products.

Our Business Goal and Growth Strategy

Our goal is to become a leading Specialty Pharmaceutical Company focused on the commercialization of Innovative, Orphan and Added Value Drugs for Greece, Cyprus and Malta.

Our strategy is to drive organic growth by leveraging our existing product portfolio, supporting recent and future product launches, acquiring and/or licensing new products, and through further development of existing molecules to better meet the needs of patients.

We Offer to our Partners

1

Market Access

We get the right treatment to the right patient at the right time, and possibly even at the right price. We generate and communicate data for the stakeholders involved in the market entry of the drug (harmonization with local legal and regulatory requirements, choice of distribution model and wholesaler, margin negotiations).

2

Commercialization

We are keen to introduce new products to our markets. We provide professional and ethical in-market promotion while respecting the highest compliance standards; this includes KOLs visits, local, national and international educational events, and sales and distribution monitoring, customer support and other key functions critical to achieving the commercial success of the new product.

3

Business Development

We are constantly seeking new ideas, initiatives, and activities that help us grow our customer base, move into new markets, develop unique strengths and build our company reputation. Strategic partnerships are essential for us. Building, managing, and leveraging such relationships that are based on trust, respect, and a mutual appreciation of each other’s value is fundamental to develop our business.

Executive Team

Alexandros Triglimas

Founder & CEO

Alexandros Triglimas is the founder and CEO of Critica Pharmaceuticals. Before starting Critica, he was a Head of Commercial Operations / Europe of Elpen Pharmaceuticals.

More…

Fay Fitrou

COO

Fay Fitrou is the COO of Critica Pharmaceuticals. She was a Head of OTC unit of Lavipharm group of Companies and the Product Manager of Castalia Laboratoires.

More…

Advisory Board

Gregory Dimakopoulos

Industry Veteran

Gregory Dimakopoulos is a Board Member of Recordati Hellas with more than thirty five years of experience in the pharmaceutical industry.

More…

Christian Duchow

Global Entrepreneur

Christian Duchow, born in Hamburg, is an entrepreneur with extensive experience in the pharmaceutical field as founder of several Healthcare companies.

More…

Perikles Konstantinides

CEO of Syracuse Main, Inc

Perikles Konstantinides is the founder and CEO of Syracuse Main, Inc. He trained as an investment banker at J.P. Morgan & Co. in New York, where he worked.

More…

Charalambos Tsoukalas

Radiopharmaceutical Expert

Dr. Tsoukalas is the Head of R&D and Production of PET Radiopharmaceuticals in Biokosmos SA. A Pharmacist with 25 years of experience in the Pharmaceutical Industry.

More…